Home/LENZ Therapeutics/Raj K. Gupta
RK

Raj K. Gupta

Chief Development Officer

LENZ Therapeutics

Therapeutic Areas

LENZ Therapeutics Pipeline

DrugIndicationPhase
LNZ100 (aceclidine)PresbyopiaPhase 3
LNZ101 (aceclidine + brimonidine)PresbyopiaPhase 3